Abstract
The MCT-1 oncogene, highly expressed in a subset of non-Hodgkin's lymphomas interacts with the cap complex through its PUA domain. MCT-1 recruits DENR, a SUI1 motif containing protein that promotes translation initiation of cancer-related mRNAs. We reasoned that a PUA-domain mutant protein would repress MCT-1 function and attenuate the malignant phenotype. Human lymphoma cell lines expressing the PUA-domain mutant protein demonstrated reduced anchorage-independent growth and increased susceptibility to apoptosis. Significantly, we identified an altered translational profile in cells expressing the mutant protein. These data further buttress the role of the MCT-1 in lymphomagenesis and support the development of novel therapeutic strategies targeting MCT-1.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 474-482 |
| Number of pages | 9 |
| Journal | Leukemia Research |
| Volume | 33 |
| Issue number | 3 |
| DOIs | |
| State | Published - Mar 2009 |
All Science Journal Classification (ASJC) codes
- Hematology
- Oncology
- Cancer Research